Prognostic value of multimodal evoked potentials in multiple sclerosis: The EP score

Journal of Neurology

Volumn 258, Issue 11, 2011, Pages 1933-1939

  Invernizzi, Paolo ^a   Bertolasi, Laura ^b   Bianchi, Maria Rachele ^b   Turatti, Marco ^b   Gajofatto, Alberto ^b   Benedetti, Maria Donata ^b  

^a UO Neurologia   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

EDSS; EP score; Evoked potentials; Multiple sclerosis; Prognosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; DISABILITY; DISEASE PREDISPOSITION; EP SCORE; EVOKED BRAIN STEM RESPONSE; EVOKED MUSCLE RESPONSE; EVOKED RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; RELAPSE; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; DISEASE COURSE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; AREA UNDER CURVE; DISEASE PROGRESSION; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84857661695     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6033-x     Document Type: Article

References (19)

1. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707-717
2. Lublin FD, Reingold SC, For the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907-911
3. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinski JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
4. Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revision to "McDonald Criteria". Ann Neurol 58:840-846
5. Swanton JK, Fernando K, Dalton CM, Miskiel KA, Thompson AJ, Plant GT, Miller DH (2006) Modification of MRI criteria for multiple sclerosisin patients with clinically isolated syndromes. J Neurol Neurosug Psychiatry 77:830-833
6. Bakshi R, Neema M, Healy BC, Liptak Z, Betansky RA, Buckle GJ, Gauthier SA, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ, Guttman RG, Weiner HL (2008) Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. Arch Neurol 65:1449-1453
7. Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15:239-245
8. Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
9. Gawne-Cain ML, O'Riordan JI, Coles A, Newell B, Thompson AJ, Miller DH (1998) MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences. J Neurol Neurosug Psychiatry 64:197-203
10. Nijeholt GT, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, Rosier PF, Jongen PJ, Barkhof F (1998) Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 121:687-973
11. Charil A, Zijdenbos AP, Taylor J, Boelman C, Worsley KJ, Evans AC, Dagher A (2003) Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 19:532-544
12. Li DKB, Held U, Petkau J, Daumer M, Barkhof F, Fazekas F, Frank JA, Kappos L, Miller DH, Simon JH, Wolinsky JS, Filippi M, For the Sylvia Lawry Centre for MS research (2006) MRI T2 lesion burden in multiple sclerosis. A plateauing relationship with clinical disability. Neurology 66:1384-1389
13. O'Connor P, Marchetti P, Lee L, Perera M (1998) Evoked potential abnormality scorse are a useful measure of disease burden in relapsing-remitting multiple sclerosis. Ann Neurol 44:404-407
14. Fuhr P, Borggrefe-Chappuis A, Schindler C, Kappos L (2001) Visual and motor evoked potentials in the course of multiple sclerosis. Brain 124:2162-2168
15. Leocani L, Rovaris M, Boneschi FM, Medaglini S, Rossi P, Martinelli V, Amadio S, Comi G (2006) Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study. J Neurol Neurosurg Psychiatry 77:1030-1035
16. Kallman BA, Fackelmann S, Toyka KV, Rieckmann P, Reiners K (2006) Early abnormalities of evoked potentials and future disability in patients with multiple sclersosis. Mult Scler 12:58-65
17. Deuschl G, Eisen A (1999) Recommendations for the practice of clinical neurophysiology: guidelines of the international federation of clinical neurophysiology. Electroencephalogr Clin Neurophysiol 52(Suppl):192-211
18. Fisher E, Lee JC, Nakamura K, Rudick RA (2008) Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 64:255-265
19. Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH (2008) Gray matter atrophy is related to long-term disability in mutiple sclerosis. Ann Neurol 64:247-254